Unicliffe Laboratories Private Limited
About Unicliffe Laboratories Private Limited
Data last updated:
Unicliffe Laboratories Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the chemical products segment of the chemicals sector. It was incorporated on 17 March 1992 and has been in existence for over 34 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH1992PTC065944.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh. It is led by directors including Sunil Vashdev Gvalani and Aditi Sunil Gvalani.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 209 Marol Bhavan Marol Co – Opindl Estate M V Road Andheri E, Mumbai, Maharashtra, India – 400059.
As per the financials filed for FY 2025, the company reported a revenue of ₹20.01 Lakh. For the same year it recorded a net profit of ₹38,247 (net margin 1.9%) and EBITDA of ₹38,524 (EBITDA margin 1.9%). Revenue has grown at a compounded annual rate (CAGR) of 33% over three years and 9% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address209 Marol Bhavan Marol Co – Opindl Estate M V Road Andheri E, Mumbai, Maharashtra, India – 400059
- IndustryChemicals, Chemical Products, Medicinal Chemical & Botanical Products, Pharmaceuticals
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Unicliffe Laboratories Private Limited FY 2025 filings available
Unicliffe Laboratories Private Limited reported revenue of ₹20.01 Lakh for FY 2025.
Compounded Annual Growth Rate (CAGR) of Unicliffe Laboratories Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 9% over five years. EBITDA rose 21% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Unicliffe Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹38,524 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹38,247 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Unicliffe Laboratories Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 1.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 1.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Unicliffe Laboratories are in the company report.
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Auditor Details of Unicliffe Laboratories Private Limited
Unicliffe Laboratories Private Limited is audited by Kanu Doshi Associates LLP for the financial year 2017.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| Kanu Doshi Associates LLP | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Unicliffe Laboratories Private Limited
Unicliffe Laboratories has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Sunil Vashdev Gvalani | Director | 17 Mar 1992 | 34 Years 6 Months | Current |
| Aditi Sunil Gvalani | Director | 26 Sep 2017 | 9 Years 0 Months | Current |
| Akshi Sunil Gvalani | Director | 22 Nov 2021 | 4 Years 10 Months | Current |
Ownership and Shareholding of Unicliffe Laboratories Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Unicliffe Laboratories Private Limited
Unicliffe Laboratories Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Unicliffe Laboratories Private Limited
Employment history and EPFO contributions of people linked to Unicliffe Laboratories.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Unicliffe Laboratories Private Limited
Unicliffe Laboratories Private Limited has 4 board changes on record since 1992: 3 appointments and 1 cessation. The latest: Akshi Sunil Gvalani was appointed as Director on 22 Nov 2021.
Credit Ratings, Litigation & Regulatory Alerts for Unicliffe Laboratories Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Unicliffe Laboratories Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Unicliffe Laboratories Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Unicliffe Laboratories Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Unicliffe Laboratories Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Unicliffe Laboratories Private Limited
Unicliffe Laboratories is an active private limited company based in Mumbai, Maharashtra, India. The company works in chemical products, within the chemicals industry. It was incorporated on 17 March 1992 (34+ years old) and is registered under CIN U24230MH1992PTC065944.
Unicliffe Laboratories reported revenue of ₹20.01 Lakh for FY 2025.
Unicliffe Laboratories has 3 current directors:
- Sunil Vashdev Gvalani - Director
- Aditi Sunil Gvalani - Director
- Akshi Sunil Gvalani - Director
Unicliffe Laboratories reported a net profit of ₹38,247 (net margin 1.9%) and EBITDA of ₹38,524 (EBITDA margin 1.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Unicliffe Laboratories is 33% over three years and 9% over five years. CAGR is the steady yearly rate that links the first and the last year.
The CIN (Corporate Identification Number) of Unicliffe Laboratories is U24230MH1992PTC065944. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unicliffe Laboratories was incorporated on 17 March 1992, making it 34+ years old. It is registered with the Registrar of Companies, Mumbai.
Akshi Sunil Gvalani was appointed as Director on 22 Nov 2021. Aditi Sunil Gvalani was appointed as Director on 26 Sep 2017. Vashdev Gvalani ceased to be Director on 29 Jul 2017. Unicliffe Laboratories has 4 board changes on record in total.
The registered office of Unicliffe Laboratories is at 209 Marol Bhavan Marol Co – Opindl Estate M V Road Andheri E, Mumbai, Maharashtra, India – 400059.
Unicliffe Laboratories has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹2 Lakh.